This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...
Depletion of CD8 T cells compromised the durability of EPN responses and reduced overall survival. These data indicate that dasatinib is an effective therapy for EPHB2-driven molecular subgroup of ...
Tumor infection with MATE-expressing oncolytic adenoviruses leads to T cell activation and tumor immunoactivation in murine tumor models, and results in a CD8-dependent therapeutic benefit.